NCT05241184

Brief Summary

Current MRI society guidelines recommend that reference ranges for specific imaging techniques (T1, T2 mapping, perfusion) are acquired on the MRI scanner that clinical work and research studies are being carried out on. We propose to undertake 32 multi parametric stress cardiac MRI scans on healthy volunteers (50% female, 50% male) over the age of 18 years. These measurements are not yet available for the 3.0T Prisma scanner at the Institute of Clinical Excellence (ICE), Queen Elizabeth University Hospital (QEUH). These values are essential to identify what is abnormal for people living in the west of Scotland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 15, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 15, 2022

Status Verified

February 1, 2022

Enrollment Period

11 months

First QC Date

February 4, 2022

Last Update Submit

February 4, 2022

Conditions

Keywords

cardiovascular magnetic resonance imagingadenosine stressparametric mappingreference rangesstrainhealthy volunteers

Outcome Measures

Primary Outcomes (5)

  • Peak stress myocardial blood (mg/ml/min)

    Peak stress myocardial blood with adenosine vasodilator stress

    Through study completion, on average <2years.

  • Myocardial perfusion reserve

    Myocardial perfusion reserve with adenosine vasodilator stress

    Through study completion, on average <2years.

  • Global and septal T1 (MOLLI, shMOLLI) T2

    reference ranges

    Through study completion, on average <2years.

  • Global and regional Circumferential strain (GCS)

    using Displacement Encoding with Stimulated Echoes (DENSE) MRI.

    Through study completion, on average <2years.

  • Global and regional Longitudinal strain (GLS)

    using Displacement Encoding with Stimulated Echoes (DENSE) MRI.

    Through study completion, on average <2years.

Interventions

Multiparametric stress CMR protocol

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers aged at least 18 years with no prior medical history (including cardiovascular health problems, medication or systemic illness including COVID-19) will be invited to participate by i) contacting eligible participants from the Clinical research imaging volunteer bank ii) placing advertisements in public buildings (e.g. hospital, university). Vaccination status for SARS Coronavirus-19 is not an exclusion criterion. The other exclusion criteria include standard contraindications to MRI (e.g. metallic implants and metallic foreign body) and known or suspected pregnancy.

You may qualify if:

  • Age 18≥years
  • Capacity to provide written informed consent
  • Able to comply with study procedures
  • eGFR \>45ml/min

You may not qualify if:

  • Contra-indication to CMR e.g. severe claustrophobia, metallic foreign body.
  • Contra-indication to intravenous adenosine, i.e. severe asthma; long QT syndrome; second- or third-degree AV block and sick sinus syndrome.
  • Lack of informed consent.
  • Women who are pregnant, breast-feeding or of child-bearing potential (WoCBP) without a negative pregnancy test
  • History of cardiovascular illness.
  • Previous COVID-19 illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth University Hospital

Glasgow, Lanarkshire, G51 4TF, United Kingdom

RECRUITING

MeSH Terms

Conditions

Sprains and Strains

Condition Hierarchy (Ancestors)

Wounds and Injuries

Central Study Contacts

Kenneth Mangion, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Lecturer in Cardiology

Study Record Dates

First Submitted

February 4, 2022

First Posted

February 15, 2022

Study Start

November 10, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

February 15, 2022

Record last verified: 2022-02

Locations